 |
PDBsum entry 2wok
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Peptide binding protein/peptide
|
PDB id
|
|
|
|
2wok
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Peptide binding protein/peptide
|
 |
|
Title:
|
 |
Clavulanic acid biosynthesis oligopeptide binding protein 2 complexed with bradykinin
|
|
Structure:
|
 |
Clavulanic acid biosynthesis oligopeptide binding protein 2. Chain: a. Synonym: orf15. Engineered: yes. Kininogen-1. Chain: b. Synonym: bradykinin,alpha-2-thiol proteinase inhibitor,fitzgerald factor,high molecular weight kininogen,hmwk,williams-fitzgerald-
|
|
Source:
|
 |
Streptomyces clavuligerus. Organism_taxid: 1901. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Homo sapiens. Human. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.187
|
R-free:
|
0.223
|
|
|
Authors:
|
 |
A.K.Mackenzie,K.Valegard,A.Iqbal,M.E.C.Caines,N.J.Kershaw,S.E.Jensen, C.J.Schofield,I.Andersson
|
|
Key ref:
|
 |
A.K.Mackenzie
et al.
(2010).
Crystal structures of an oligopeptide-binding protein from the biosynthetic pathway of the beta-lactamase inhibitor clavulanic acid.
J Mol Biol,
396,
332-344.
PubMed id:
|
 |
|
Date:
|
 |
|
26-Jul-09
|
Release date:
|
08-Dec-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q8KRB4
(Q8KRB4_STRCL) -
ABC-type dipeptide transport system, solute-binding protein from Streptomyces clavuligerus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
562 a.a.
553 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Mol Biol
396:332-344
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of an oligopeptide-binding protein from the biosynthetic pathway of the beta-lactamase inhibitor clavulanic acid.
|
|
A.K.Mackenzie,
K.Valegård,
A.Iqbal,
M.E.Caines,
N.J.Kershaw,
S.E.Jensen,
C.J.Schofield,
I.Andersson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Clavulanic acid (CA) is a clinically important beta-lactamase inhibitor that is
produced by fermentation of Streptomyces clavuligerus. The CA biosynthesis
pathway starts from arginine and glyceraldehyde-3-phosphate and proceeds via
(3S,5S)-clavaminic acid, which is converted to (3R,5R)-clavaldehyde, the
immediate precursor of (3R,5R)-CA. Open reading frames 7 (orf7) and 15 (orf15)
of the CA biosynthesis cluster encode oligopeptide-binding proteins (OppA1 and
OppA2), which are essential for CA biosynthesis. OppA1/2 are proposed to be
involved in the binding and/or transport of peptides across the S. clavuligerus
cell membrane. Peptide binding assays reveal that recombinant OppA1 and OppA2
bind di-/tripeptides containing arginine and certain nonapeptides including
bradykinin. Crystal structures of OppA2 in its apo form and in complex with
arginine or bradykinin were solved to 1.45, 1.7, and 1.7 A resolution,
respectively. The overall fold of OppA2 consists of two lobes with a deep cavity
in the center, as observed for other oligopeptide-binding proteins. The large
cavity creates a peptide/arginine binding cleft. The crystal structures of OppA2
in complex with arginine or bradykinin reveal that the C-terminal arginine of
bradykinin binds similarly to arginine. The results are discussed in terms of
the possible roles of OppA1/2 in CA biosynthesis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.Nárdiz,
I.Santamarta,
L.M.Lorenzana,
J.F.Martín,
and
P.Liras
(2011).
A rhodanese-like protein is highly overrepresented in the mutant S. clavuligerus oppA2::aph: effect on holomycin and other secondary metabolites production.
|
| |
Microb Biotechnol,
4,
216-225.
|
 |
|
|
|
|
 |
J.Y.Song,
S.E.Jensen,
and
K.J.Lee
(2010).
Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
|
| |
Appl Microbiol Biotechnol,
88,
659-669.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |